temas especiales
Cardo lechoso
Referencias
1.Abenavoli L, Izzo AA, Milic N, et al: Milk thistle (Silybum marianum): a concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases.Phytother Res32(11):2202-2213, 2018. doi: 10.1002/ptr.6171 2.Hadi A, Pourmasoumi M, Mohammadi H, et al: The effects of silymarin supplementation on metabolic status and oxidative stress in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of clinical trials.Complement Ther Med41:311-319, 2018. doi: 10.1016/j.ctim.2018.08.010 3.Ward J, Kapadia K, Brush E, et al: Amatoxin poisoning: case reports and review of current therapies.J Emerg Med44(1):116-121, 2013. doi: 10.1016/j.jemermed.2012.02.020 4.Rambaldi A, Jacobs BP, Gluud C: Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases.Cochrane Database Syst Rev(4)CD003620, 2007. doi: 10.1002/14651858.CD003620.pub3 5.Yang Z, Zhuang L, Lu Y, et al: Effects and tolerance of silymarin (milk thistle) in chronic hepatitis C virus infection patients: a meta-analysis of randomized controlled trials.Biomed Res Int941085, 2014. doi: 10.1155/2014/941085 6.Valenzuela A, Aspillaga M, Vial S, et al: Selectivity of silymarin on the increase of the glutathione content in different tissues of the rat.Planta Med55(5):420-422, 1989. doi: 10.1055/s-2006-962056 7.Xiao F, Gao F, Zhou S, et al: The therapeutic effects of silymarin for patients with glucose/lipid metabolic dysfunction: a meta-analysis.Medicine (Baltimore)99(40):e22249, 2020. doi:10.1097/MD.0000000000022249 8.Wu JW, Lin LC, Tsai TH: Drug-drug interactions of silymarin on the perspective of pharmacokinetics.J Ethnopharmacol121(2):185-193, 2009. doi: 10.1016/j.jep.2008.10.036 9.Jalloh MA, Gregory PJ, Hein D, et al: Dietary supplement interactions with antiretrovirals: a systematic review.Int J STD AIDS28(1):4-15, 2017. doi: 10.1177/0956462416671087 